三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

News

Understand the latest news of Leadingpharm

Academician Mao Zhenbin and His Delegation from FDSA Visited Leadingpharm, Jointly Explore the High-quality Development of the Industry

Release time:2024-03-15

In order to promote the development of the food and drug industry towards higher quality, assist in the comprehensive improvement of the national food and drug safety strategy and technological innovation, Academician Mao Zhenbin, President of the China Food and Drug Corporation Quality and Safety Promotion Association(FDSA),and Mr. Huang Xinwang, vice President of FDSA, and the delegation recently visited the Beijing Research Institute of Leadingpharm (Vice President Unit of FDSA), and had an in-depth and effective exchange and cooperation with the leadership team of Leadingpharm.
 

In order to promote the development of the food and drug industry towards higher quality, assist in the comprehensive improvement of the national food and drug safety strategy and technological innovation, Academician Mao Zhenbin, President of the China Food and Drug Corporation Quality and Safety Promotion Association(FDSA),and Mr. Huang Xinwang, vice President of FDSA, and the delegation recently visited the Beijing Research Institute of Leadingpharm (Vice President Unit of FDSA), and had an in-depth and effective exchange and cooperation with the leadership team of Leadingpharm.
 

Both sides agree that regulatory science is the key to enhancing drug regulatory capacity and governance level, and it is also an important support for China to be a pharmaceutical powerhouse. In the current era of pharmaceutical innovation, attention should be paid to the application and integration of regulatory science in real-world research and innovative drug development, which can more accurately evaluate the effectiveness and safety of drugs in clinical practice, and provide more comprehensive and authentic data support for policy makers, clinical institutions and pharmaceutical R&D enterprises.
 

During the meeting, both sides also exchanged ideas on the construction and development of innovative pharmaceutical brands. Leadingpharm has demonstrated outstanding R&D capabilities and profound industry experience in the entire CXO industry chain, always guided by regulatory science. Based on top-level design of scientific regulation, it is committed to providing innovative pharmaceutical enterprises with comprehensive and full lifecycle innovation services, from technology research and development to product registration, smooth transformation from IND to NDA, and maximization of product commercial value, helping enterprises to develop rapidly and continuously innovate in the pharmaceutical field. The China Food and Drug Enterprise Quality and Safety Promotion Association, as an important force in promoting industry development, actively builds platforms to promote deep integration of industry, academia, research and application. Both sides stated that they will rely on the platform of FDSA and combine the advantages of the entire industry chain of Leadingpharm to jointly build a drug innovation service committee with regulatory science as the main line, play a positive role in providing consultation to the government, serving enterprise development, optimizing resource allocation, strengthening industry self-discipline, innovating social governance, fulfilling social responsibilities, and other aspects.
 

In the field of real-world research, the cooperation between the two sides also shows a trend of deep integration. The research and application of real-world data provide more realistic and accurate data support for drug development and transformation, which helps to improve the quality and efficiency of drug development. Leadingpharm has rich experience and resources in this field, and will work together with FDSA to explore the application mode of real-world data in drug research and development transformation, promoting the speed of innovative drug research and marketing. Both parties will also jointly develop research standards, improve data collection and analysis methods, and enhance the scientific and practical nature of the research.
 

This visit and exchange not only demonstrate the joint responsibility of associations and enterprises in promoting high-quality development of the industry, but also indicate that China's food and drug industry will take more solid steps on the path of regulatory science and innovative development. In the future, both sides will continue to deepen cooperation and jointly contribute wisdom and strength to the prosperity and development of China's pharmaceutical industry.

轉載聲明:未經(jīng)本網(wǎng)或本網(wǎng)權利人授權,不得轉載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權利人授權使用作品的,應在授權范圍內使用,并注明“來源:新領先醫(yī)藥科技”。

Recommend

久久这里只精品中文字幕| 国产欧美日韩精品在线看| 国产精品柳州莫菁身材四| 国产日韩欧美在线一区二区 | 成人黄色免费在线观看网站| 国产精品一区二区成毛片| 稀缺久av在线| 成年人在线观看免费毛片| 日中文字幕一区二区三区| 下一篇中文字幕人妻精品| 亚洲欧洲一区二区综合精品| 久久久久亚洲av无码专区首| 18禁在线毛片| 日本精品视频一区二区三区| 伊人一区二区三区久久精品| 久久亚洲中文字幕无码| 人妻激情偷一区二区三区| 国产主播福利片在线观看| 精品成人午夜久久久久久| 亚洲成在线观看无码不卡| 国产小视频免费在线观看| 亚洲 国产 精品 无码| av高清理伦片在线观看| 日韩欧美一区二区一级电影| 国产精品美脚玉足脚交欧美| 日本精品一区二区三区高清| 国产亚洲精品99999| 国产欧美日韩精品在线看| 亚洲黄色美女网站999| 亚洲日韩精品欧美一区二区| 蜜臀AⅤ国产精品久久久| 无码人妻| 人妻丰满熟妇av无码区免| 久久国产精品广西柳州门| 国产一二三区精品亚洲美女| 国产精品成人一区二区1| 天天揉久久久久亚洲精品| 男女上下插动态在线视频| 成人区人妻无码视频精品| 亚洲a∨在线播无码av| 日韩不卡av手机在线播放|